273 related articles for article (PubMed ID: 29536556)
1. Lymphocyte apheresis for chimeric antigen receptor T-cell manufacturing in children and young adults with leukemia and neuroblastoma.
Ceppi F; Rivers J; Annesley C; Pinto N; Park JR; Lindgren C; Mgebroff S; Linn N; Delaney M; Gardner RA
Transfusion; 2018 Jun; 58(6):1414-1420. PubMed ID: 29536556
[TBL] [Abstract][Full Text] [Related]
2. Autologous lymphapheresis for the production of chimeric antigen receptor T cells.
Allen ES; Stroncek DF; Ren J; Eder AF; West KA; Fry TJ; Lee DW; Mackall CL; Conry-Cantilena C
Transfusion; 2017 May; 57(5):1133-1141. PubMed ID: 28236305
[TBL] [Abstract][Full Text] [Related]
3. Unstimulated apheresis for chimeric antigen receptor manufacturing in pediatric/adolescent acute lymphoblastic leukemia patients.
Jarisch A; Rettinger E; Sörensen J; Klingebiel T; Schäfer R; Seifried E; Bader P; Bonig H
J Clin Apher; 2020 Sep; 35(5):398-405. PubMed ID: 32750197
[TBL] [Abstract][Full Text] [Related]
4. Current Challenges in Providing Good Leukapheresis Products for Manufacturing of CAR-T Cells for Patients with Relapsed/Refractory NHL or ALL.
Korell F; Laier S; Sauer S; Veelken K; Hennemann H; Schubert ML; Sauer T; Pavel P; Mueller-Tidow C; Dreger P; Schmitt M; Schmitt A
Cells; 2020 May; 9(5):. PubMed ID: 32429189
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting lymphocyte collection efficiency for the manufacture of chimeric antigen receptor T cells in adults with B-cell malignancies.
Tuazon SA; Li A; Gooley T; Eunson TW; Maloney DG; Turtle CJ; Linenberger ML; Connelly-Smith LS
Transfusion; 2019 May; 59(5):1773-1780. PubMed ID: 30729531
[TBL] [Abstract][Full Text] [Related]
6. Optimizing autologous nonmobilized mononuclear cell collections for cellular therapy in pediatric patients with high-risk leukemia.
Even-Or E; Di Mola M; Ali M; Courtney S; McDougall E; Alexander S; Schechter T; Whitlock JA; Licht C; Krueger J
Transfusion; 2017 Jun; 57(6):1536-1542. PubMed ID: 28439898
[TBL] [Abstract][Full Text] [Related]
7. Apheresis for chimeric antigen receptor T-cell production in adult lymphoma patients.
Harrer DC; Heidenreich M; Fante MA; Müller V; Haehnel V; Offner R; Burkhardt R; Herr W; Edinger M; Wolff D; Thomas S; Brosig A
Transfusion; 2022 Aug; 62(8):1602-1611. PubMed ID: 35851959
[TBL] [Abstract][Full Text] [Related]
8. Automated collection of peripheral blood stem cells with the COBE spectra for autotransplantation.
Heuft HG; Dubiel M; Kingreen D; Oertel J; De Reys S; Rick O; Serke S; Schwella N
Vox Sang; 2000; 79(2):94-9. PubMed ID: 11054047
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of leukapheresis for CAR T-cell production in heavily pre-treated pediatric patients.
Hutt D; Bielorai B; Baturov B; Z'orbinski I; Ilin N; Adam E; Itzhaki O; Besser MJ; Toren A; Jacoby E
Transfus Apher Sci; 2020 Aug; 59(4):102769. PubMed ID: 32414613
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cell collection efficiency in non-mobilized adult donors for autologous chimeric antigen receptor T-cell manufacturing.
Piñeyroa JA; Cid J; Vlagea A; Carbassé G; Henao P; Bailo N; Ortiz-Maldonado V; Martínez-Cibrian N; Español M; Delgado J; Urbano-Ispizua Á; Lozano M
Vox Sang; 2023 Mar; 118(3):217-222. PubMed ID: 36516201
[TBL] [Abstract][Full Text] [Related]
11. Absolute lymphocyte count recovery following initial acute myelogenous leukemia therapy: Implications for adoptive cell therapy.
Molina JC; Li Y; Otto WR; Miller TP; Getz KD; Mccoubrey C; Ramos M; Krause E; Cao L; Gramatges MM; Rabin K; Scheurer M; Elgarten CW; Myers RM; Seif AE; Fisher BT; Shah NN; Aplenc R
Pediatr Blood Cancer; 2023 Jan; 70(1):e30062. PubMed ID: 36370087
[TBL] [Abstract][Full Text] [Related]
12. Optimization of lymphapheresis for manufacturing autologous CAR-T cells.
Yamanaka I; Yamauchi T; Henzan T; Sakoda T; Miyamoto K; Mishima H; Ono H; Koga Y; Nakashima Y; Kato K; Miyamoto T; Mizuno S; Ogawa Y; Ohga S; Akashi K; Maeda T; Kunisaki Y
Int J Hematol; 2021 Oct; 114(4):449-458. PubMed ID: 34275066
[TBL] [Abstract][Full Text] [Related]
13. [Clinical experience of leukapheresis for CD19 CAR-T cell therapy].
Jo T; Yoshihara S; Arai Y; Ikemoto J; Onomoto H; Sugiyama H; Yoshihara K; Matsui K; Niwa N; Nakagawa Y; Kitawaki T; Kanda J; Takaori-Kondo A; Nagao M
Rinsho Ketsueki; 2021; 62(3):163-169. PubMed ID: 33828008
[TBL] [Abstract][Full Text] [Related]
14. First comparative evaluation of a new leukapheresis technology in non-cytokine-stimulated donors.
Steininger PA; Strasser EF; Weiss D; Achenbach S; Zimmermann R; Eckstein R
Vox Sang; 2014 Apr; 106(3):248-55. PubMed ID: 24152115
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of peripheral blood stem cell collection in large-volume leukapheresis for pediatric patients undergoing chemotherapy and adult patients before chemotherapy.
Yamaguchi E; Yamato K; Miyata Y
J Hematother Stem Cell Res; 2000 Aug; 9(4):565-72. PubMed ID: 10982257
[TBL] [Abstract][Full Text] [Related]
16. Lack of defined apheresis collection criteria in publicly available CAR-T cell clinical trial descriptions: Comprehensive review of over 600 studies.
Thibodeaux SR; Aqui NA; Park YA; Schneiderman J; Su LL; Winters JL; Zubair AC; Schwartz J; Liu HD;
J Clin Apher; 2022 Jun; 37(3):223-236. PubMed ID: 35085413
[TBL] [Abstract][Full Text] [Related]
17. Combined heparin/acid citrate dextrose solution A anticoagulation in the Optia continuous mononuclear cell protocol for pediatric lymphocyte apheresis.
DeSimone RA; Myers GD; Guest EM; Shi PA
J Clin Apher; 2019 Aug; 34(4):487-489. PubMed ID: 30489654
[TBL] [Abstract][Full Text] [Related]
18. A Clinically Applicable Prediction Model to Improve T Cell Collection in Chimeric Antigen Receptor T Cell Therapy.
Jo T; Yoshihara S; Hada A; Arai Y; Kitawaki T; Ikemoto J; Onomoto H; Sugiyama H; Yoshihara K; Obi N; Matsui K; Niwa N; Nakagawa Y; Kanda J; Kondo T; Saida S; Kato I; Hiramatsu H; Adachi S; Takita J; Takaori-Kondo A; Nagao M
Transplant Cell Ther; 2022 Jul; 28(7):365.e1-365.e7. PubMed ID: 35460928
[TBL] [Abstract][Full Text] [Related]
19. Managing leukapheresis in adult and pediatric patients eligible for chimeric antigen receptor T-cell therapy: suggestions from an Italian Expert Panel.
Leone G; Baldini V; Bramanti S; Crocchiolo R; Gattillo S; Ermini S; Giudice V; Ferrero I; Moscato T; Milani R; Gozzer M; Piccirillo N; Tassi C; Tassi V; Coluccia P
Blood Transfus; 2023 Nov; 21(6):514-525. PubMed ID: 37146295
[TBL] [Abstract][Full Text] [Related]
20. [Manufacturing results of tisagenlecleucel for acute lymphoblastic leukemia: a survey by the CAR-T cell therapy taskforce of the Japan Society of Transfusion Medicine and Cell Therapy].
Jo T; Henzan T; Tomizawa D; Yoshihara S; Kahata K; Yamada-Fujiwara M; Okuyama Y; Shiba N; Fujii K; Umezawa Y; Yamazaki R; Takeda W; Hanajiri R; Fukushima K; Mimura N; Ikemoto J; Iwaki K; Yonetani N; Fujiwara SI; Ri M; Nagamura-Inoue T; Tanosaki R; Arai Y
Rinsho Ketsueki; 2023; 64(5):331-337. PubMed ID: 37271521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]